These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 35663977)
21. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma. Sun K; Chen RX; Li JZ; Luo ZX Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179 [TBL] [Abstract][Full Text] [Related]
22. Comprehensive analysis of zinc and ring finger 3 in prognostic value and pan-cancer immunity. Liu M; Zhao H; Peng S; Wu Y; Liu Y; Sun W; Zen K; Sun X FASEB J; 2024 Mar; 38(5):e23523. PubMed ID: 38457275 [TBL] [Abstract][Full Text] [Related]
23. Differential Expression of the Hu J; Xu J; Feng X; Li Y; Hua F; Xu G Front Cell Dev Biol; 2021; 9():700661. PubMed ID: 34631699 [TBL] [Abstract][Full Text] [Related]
24. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma. Zuo S; Wei M; Wang S; Dong J; Wei J Front Immunol; 2020; 11():1218. PubMed ID: 32714316 [No Abstract] [Full Text] [Related]
25. The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression. Zhang Z; Li L; Li M; Wang X Comput Struct Biotechnol J; 2020; 18():2438-2444. PubMed ID: 32905022 [TBL] [Abstract][Full Text] [Related]
26. Non-SMC condensin I complex subunit D2 (NCAPD2) reveals its prognostic and immunologic features in human cancers. Dong X; Liu T; Li Z; Zhai Y Aging (Albany NY); 2023 Jul; 15(14):7237-7257. PubMed ID: 37498296 [TBL] [Abstract][Full Text] [Related]
27. Pan-cancer analysis reveals the pro-oncogenic role of N6-methyladenosine (m6A)-regulated NTMT1 in head and neck squamous cell carcinoma. Zhao C; Yu M; Li Y J Biochem Mol Toxicol; 2024 Jan; 38(1):e23603. PubMed ID: 38014887 [TBL] [Abstract][Full Text] [Related]
28. Single-cell analysis of multiple cancer types reveals differences in endothelial cells between tumors and normal tissues. Zhang J; Lu T; Lu S; Ma S; Han D; Zhang K; Xu C; Liu S; Gan L; Wu X; Yang F; Wen W; Qin W Comput Struct Biotechnol J; 2023; 21():665-676. PubMed ID: 36659929 [TBL] [Abstract][Full Text] [Related]
29. CDK1 Acts as a Prognostic Biomarker Associated with Immune Infiltration in Pan-Cancer, Especially in Gastrointestinal Tumors. Shen J; Gong X; Tan S; Zhang Y; Xia R; Xu S; Wang S; Zhou H; Jiang Y; Zhao T; Zhang Y; Tang H; Wang C Curr Med Chem; 2024 Jun; ():. PubMed ID: 38952160 [TBL] [Abstract][Full Text] [Related]
30. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity. Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695 [TBL] [Abstract][Full Text] [Related]
31. SHMT2 is Associated with Tumor Purity, CD8+ T Immune Cells Infiltration, and a Novel Therapeutic Target in Four Different Human Cancers. Usman M; Hameed Y; Ahmad M; Iqbal MJ; Maryam A; Mazhar A; Naz S; Tanveer R; Saeed H; Bint-E-Fatima ; Ashraf A; Hadi A; Hameed Z; Tariq E; Aslam AS Curr Mol Med; 2023; 23(2):161-176. PubMed ID: 35023455 [TBL] [Abstract][Full Text] [Related]
32. A comprehensive pan-cancer analysis of the expression characteristics, prognostic value, and immune characteristics of Fei L; Lu Z; Xu Y; Hou G Front Genet; 2022; 13():920897. PubMed ID: 36035140 [No Abstract] [Full Text] [Related]
33. Pan-Cancer Analysis on the Oncogenic Role of Programmed Cell Death 10. Sun N; Li C; Teng Y; Deng Y; Shi L J Oncol; 2022; 2022():1242658. PubMed ID: 36276268 [TBL] [Abstract][Full Text] [Related]
34. Significance of Chr9p22.1-p21.3 Deletion in Cancer Development: A Pan-cancer Gonçalves PG; Reis RM; Bidinotto LT Anticancer Res; 2022 Nov; 42(11):5291-5304. PubMed ID: 36288884 [TBL] [Abstract][Full Text] [Related]
35. Bioinformatic Analysis Reveals Bone Marrow Kinase as a Potential Diagnostic and Prognostic Biomarker for Multiple Cancer Types. Khalafallah SA; Eltayeb Ahmed EA; Elnour LS; Mohammed R; Makawi A; Mohamed AK; Balla A; Alamin MF; Alfaki M Cureus; 2024 Aug; 16(8):e68093. PubMed ID: 39347140 [TBL] [Abstract][Full Text] [Related]
37. ASPM Is a Prognostic Biomarker and Correlates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma. Deng T; Liu Y; Zhuang J; Tang Y; Huo Q Front Oncol; 2022; 12():632042. PubMed ID: 35515103 [TBL] [Abstract][Full Text] [Related]
38. Characterization of total adenosine deaminase activity (ADA) and its isoenzymes in saliva and serum in health and inflammatory conditions in four different species: an analytical and clinical validation pilot study. Contreras-Aguilar MD; Tvarijonaviciute A; Monkeviciene I; Martín-Cuervo M; González-Arostegui LG; Franco-Martínez L; Cerón JJ; Tecles F; Escribano D BMC Vet Res; 2020 Oct; 16(1):384. PubMed ID: 33046093 [TBL] [Abstract][Full Text] [Related]
39. Elucidating the pan-oncologic landscape of S100A9: prognostic and therapeutic corollaries from an integrative bioinformatics and Mendelian randomization analysis. Chen Y; Wu Z; Yi X Sci Rep; 2024 Aug; 14(1):19071. PubMed ID: 39154046 [TBL] [Abstract][Full Text] [Related]
40. Epigenetic-Mediated Downregulation of Zinc Finger Protein 671 ( Zhang J; Zheng Z; Zheng J; Xie T; Tian Y; Li R; Wang B; Lin J; Xu A; Huang X; Yuan Y Front Oncol; 2019; 9():342. PubMed ID: 31134149 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]